Autonomix Medical Surges 117% After Hours on $4.9M Financing

Autonomix Medical Inc. shares surged 116.57% in after-hours trading Monday after the company announced a $4.9 million warrant incentive transaction.

The stock closed Monday's regular session up 1.90% at $5.37, then jumped 116.57% to $11.63 in after-hours trading.

Autonomix Medical is a medical device company focused on developing precision nerve-targeting therapeutic technology.

$4.9 Million Warrant Incentive

Autonomix said it entered into a warrant incentive agreement with an investor who will immediately exercise existing warrants to purchase 857,462 shares at $5.75 per share.

The company expects to receive approximately $4.9 million in gross proceeds, before deducting financial advisor fees and estimated offering expenses.

The transaction is expected to close on or around August 26, subject to customary closing conditions.

As part of the agreement, Autonomix will issue the investor E-1 and E-2 series warrants, collectively exercisable for 1.07 million shares. The new warrants have an exercise price of $6.25 per share and expire five years from the date of issuance.

Focus on Neural Targeting Therapy

Autonomix is developing a catheter-based microchip sensing array designed to detect and differentiate neural signals with greater sensitivity than existing technologies.

The company initially developed the platform for pain treatment, with early trials focused on pancreatic cancer. The company said the technology may also have applications in cardiology, hypertension, and chronic pain management.

The company stated its technology remains in the research stage and has not yet received U.S. marketing clearance.

Stock Performance

Autonomix Medical has a market capitalization of $5.21 million, with a 52-week high of $32.55 and a 52-week low of $2.44.

AMIX stock has declined 74.93% over the past year. The company's Edge stock ranking shows AMIX stock exhibiting negative price trends across all time frames.